Mythic Therapeutics
Waltham, US · Founded 2018 · Delaware corporation · 4 known investors
Founders & leadership
Mythic Therapeutics was founded in 2018 by Brian Fiske.
BF
Brian FiskeFounder
GE
George EliadesinExecutive
SP
Sandra PooleExecutive
AN
Alex NicholsNamed on SEC filing
Board
BR
Bryan RobertsBoard director
PH
Peter HechtBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$53.5M disclosed across 3 rounds · 2018–2024
▶$29.9MraisedDec 2024 · 30 investors · BiotechnologyRule 506(b)
▶$29.9MraisedDec 2024 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- George EliadesExecutive Officer, Director
- Bryan RobertsDirector
- Peter HechtDirector
- Sandra PooleExecutive Officer
- Brian FiskeExecutive Officer, Director
- Offering amount
- $30.4M
- Amount sold
- $29.9M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.7MraisedAug 2020 · 21 investors · BiotechnologyRule 506(b)
▶$4.7MraisedAug 2020 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alex NicholsExecutive Officer, Director, Promoter
- Brian FiskeExecutive Officer, Director, Promoter
- Offering amount
- $4.7M
- Amount sold
- $4.7M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$18.8MraisedAug 2020 · 18 investors · BiotechnologyRule 506(b)
▶$18.8MraisedAug 2020 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jason HansonDirector
- Josh KopelmanDirector
- Bryan RobertsDirector
- Alex NicholsExecutive Officer, Director, Promoter
- Brian FiskeExecutive Officer, Director, Promoter
- Offering amount
- $18.8M
- Amount sold
- $18.8M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapBioworld15 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Dialectic Therapeutics15 shared keywordsDialectic Therapeutics is a clinical-stage biotechnology company developing anti-cancer drugs using its Antiapoptotic Protein Targeted Degradation (APTaD) platform, which induces cancer cells to degrade proteins such as BCL-XL. Its lead candidate, DT2216, is in Phase 1/2 trials for fibrolamellar carcinoma and platinum-resistant ovarian cancer.
Solu13 shared keywordsSolu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels. Its pipeline targets oncology, immunology and inflammation, and pain, with a lead program in Phase 1 trials for chronic myelomonocytic leukemia.
Context Therapeutics11 shared keywordsContext Therapeutics develops clinical-stage T cell engaging bispecific antibody therapies for the treatment of solid tumors. Its pipeline targets antigens such as Claudin 6, mesothelin, and Nectin-4 to direct the immune system against difficult-to-treat cancers.
Companies competing with Mythic Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- Who founded Mythic Therapeutics?
- Mythic Therapeutics was founded by Brian Fiske in 2018.
- Who are Mythic Therapeutics's investors?
- Mythic Therapeutics's investors include Hemi Ventures, Llc, Lifeforce Capital, Refactor Capital, Venrock Associates.
- How much funding has Mythic Therapeutics raised?
- Mythic Therapeutics has disclosed $53.5M raised across 3 rounds.
- Where is Mythic Therapeutics headquartered?
- Mythic Therapeutics is headquartered in Waltham, US.